Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07543497
Clinical Trial
Performance and Impact of the Sepsis ImmunoScore
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.
Trial Details
NCT Number
NCT07543497
Lead Sponsor
Prenosis, Inc.
Conditions
Sepsis
Enrollment
5,000 participants
Start Date
2026-04
Primary Completion
2027-12
(estimated)
Study Completion
2027-12
(estimated)
Updated on ClinicalTrials.gov
2026-04-22